The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers

Human Pathology

Volumn 37, Issue 9, 2006, Pages 1123-1129

  Shimada, Shio ^a   Ishizawa, Takashi ^a   Ishizawa, Keisuke ^a   Matsumura, Tadaki ^b   Hasegawa, Tadashi ^b   Hirose, Takanori ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDK4; Liposarcoma; MDM2; MFH; Real time PCR

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC DISORDER; HISTOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MYXOSARCOMA; NERVE SHEATH TUMOR; PERIPHERAL NERVE; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE 4; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE AMPLIFICATION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33747858764     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.04.010     Document Type: Article

References (35)

1. Dei Tos A.P., and Pedeutour F. Atypical lipomatous tumour/well differentiated liposarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone (2002), IARC Press, Lyon 35-37
2. Dei Tos A.P., and Pedeutour F. Dedifferentiated liposarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization Classification of tumours. Pathology and genetics of tumours of soft tissue and bone (2002), IARCPress, Lyon 38-39
3. Pedeutour F., Suijkerbuijk R.F., Forus A., et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 10 (1994) 85-94
4. Rosai J., Akerman M., Dal Cin P., et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol 20 (1996) 1182-1189
5. Pedeutour F., Forus A., Coindre J.M., et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24 (1999) 30-41
6. Pilotti S., Della Torre G., Lavarino C., et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181 (1997) 14-24
7. Schneider-Stock R., Walter H., Radig K., et al. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 124 (1998) 532-540
8. Pilotti S., Della Torre G., Lavarino C., et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol 185 (1998) 188-190
9. Dei Tos A.P., Doglioni C., Piccinin S., et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 190 (2000) 531-536
10. Pilotti S., Della Torre G., Mezzelani A., et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 82 (2000) 1271-1275
11. Forus A., Bjerkehagen B., Sirvent N., et al. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genet Cytogenet 131 (2001) 13-18
12. Hostein I., Coindre J.M., Derre J., et al. Comparative genomic hybridization study of paraffin-embedded dedifferentiated liposarcoma fixed with Holland Bouin's fluid. Diagn Mol Pathol 12 (2003) 166-173
13. Hostein I., Pelmus M., Aurias A., et al. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well differentiated liposarcomas. J Pathol 202 (2004) 95-102
14. Coindre J.M., Mariani O., Chibon F., et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 16 (2003) 256-262
15. Bartel F., Meye A., Wurl R., et al. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 mRNA, is associated with prognosis in soft tissue sarcoma. Int J Cancer 95 (2001) 168-175
16. Nakayama T., Toguchida J., Wadayama B., et al. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer 64 (1995) 342-346
17. Nilbert M., Rydholm A., Mitelman F., et al. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 83 (1995) 32-36
18. Kanoe H., Nakayama T., Murakami H., et al. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Anticancer Res 18 (1998) 2317-2321
19. Leach F.S., Tokino T., Meltzer P., et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53 (1993) 2231-2234
20. Florenes V.A., Malandsmo G.M., Forus A., et al. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J Natl Cancer Inst 86 (1994) 1297-1302
21. Yoo J., Park S.Y., Kang S.J., et al. Altered expression of G1 regulatory proteins in human soft tissue sarcomas. Arch Pathol Lab Med 126 (2002) 567-573
22. Rieske P., Bartkowiak J.K., Szadowska A.M., et al. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. J Exp Clin Cancer Res 18 (1999) 403-416
23. Binh M.B.N., Sastre-Garau X., Cuillou L., et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtype. Am J Surg Pathol 29 (2005) 1340-1347
24. Shimada S., Ishizawa T., Ishizawa K., et al. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation. Virchows Archiv 447 (2005) 835-841
25. Kitayama Y., Igarashi H., and Sugimura H. Amplification of FISH signals using intermittent microwave irradiation for analysis of chromosomal instability in gastric cancer. Mol Pathol 52 (1999) 357-359
26. Kitayama Y., Igarashi H., and Sugimura H. Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: stage-dependent analysis by FISH with the use of microwave irradiation. Clin Cancer Res 6 (2000) 3139-3146
27. Okada Y., Hurwitz E.E., Esposito J.M., et al. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 63 (2003) 413-416
28. Coindre J.M., Hostein I., Maire G., et al. Inflammatory malignant fibrous histiocytoma and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203 (2004) 822-830
29. Chibon F., Mariani O., Mairal A., et al. The use of clustering software for the classification of comparative genomic hybridization data. An analysis of 109 malignant fibrous histiocytomas. Cancer Genet Cytogenet 141 (2003) 75-78
30. Chibon F., Mariani O., Derre J., et al. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications. Genes Chromosomes Cancer 40 (2004) 32-37
31. Chibon F., Mariani O., Derre J., et al. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 139 (2002) 24-29
32. Fletcher C.D.M., van den Berg E., and Molenaar W.M. Pleomorphic malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma. In: Fletcher C., Unni K., and Mertens F. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone (2002), IARC Press, Lyon 120-122
33. Hill D.A., O'Sullivan M.J., Zhu X., et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 26 (2002) 965-977
34. Hisaoka M., Tsuji S., Morimitsu Y., et al. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn Mol Pathol 7 (1998) 96-101
35. Panagopoulos I., Lassen C., Isaksson M., et al. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia. Oncogene 15 (1997) 1357-1362